Ainos (OTCMKTS:AIMD) Stock Price Down 5% – Should You Sell?

Ainos, Inc. (OTCMKTS:AIMD)’s share price dropped 5% on Thursday . The company traded as low as $0.45 and last traded at $0.48. Approximately 415,549 shares changed hands during trading, a decline of 10% from the average daily volume of 461,247 shares. The stock had previously closed at $0.51.

Ainos Stock Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92. The stock has a fifty day simple moving average of $0.56 and a two-hundred day simple moving average of $0.56. The stock has a market capitalization of $10.01 million, a price-to-earnings ratio of -0.55 and a beta of 2.20.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.